Clinical Trials Directory

Trials / Unknown

UnknownNCT02592694

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in ST-elevation Myocardial Infarction Patients Treated With Primary Angioplasty

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double blind, placebo controlled study of intracoronary cocktail injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation myocardial infarction patients treated with primary angioplasty.

Detailed description

This is a randomized, double blind, placebo controlled study of intracoronary cocktail injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation myocardial infarction patients treated with primary angioplasty. Patients with STEMI will be randomized into the cocktail group or the control group. Patients in the cocktail group will receive cocktail injection combined with thrombus aspiration. Patients in the control group will receive thrombus aspiration alone. The primary outcome of the cocktail I study is the composite of death, myocardial infarction or class IV heart failure within 1 year. The secondary outcome of the cocktail I study include slow reflow/no reflow during PCI, left ventricular function, quality of life, stroke or life-threatening bleeding within 1 year.

Conditions

Interventions

TypeNameDescription
DRUGcocktailCocktail (tirofiban, bivalirudin, tenecteplase) will be given in addition to thrombus aspiration
DEVICEthrombus aspirationmanual thrombus aspiration

Timeline

Start date
2015-10-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2015-10-30
Last updated
2015-10-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02592694. Inclusion in this directory is not an endorsement.